I Klimeś

Switching from Insulin to Oral Sulfonylureas in Patients with Diabetes Due to Kir6.2 Mutations

Ewan R. Pearson, Isabelle Flechtner, Pål R. Njølstad et al. · New England Journal of Medicine · 2006 · 979 citations · Full text

Effects of obesity, diabetes and exercise on <i>Fndc5</i> gene expression and irisin release in human skeletal muscle and adipose tissue: <i>in vivo</i> and <i>in vitro</i> studies

Tímea Kurdiová, Miroslav Baláž, M Vician et al. · The Journal of Physiology · 2013 · 394 citations · Full text

Insulin Therapy in Obese, Non-insulin-dependent Diabetes Induces Improvements in Insulin Action and Secretion that Are Maintained for Two Weeks After Insulin Withdrawal

W John Andrews, Barbara Vasquez, M. Nagulesparan et al. · Diabetes · 1984 · 190 citations

Insulin Clamp, Glucose Tolerance, Insulin Signaling +18

Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study

Pamela Bowman, Åsta Sulen, Fabrizio Barbetti et al. · The Lancet Diabetes & Endocrinology · 2018 · 169 citations · Full text

Insulin Sensitivity Indices: a Proposal of Cut-Off Points for Simple Identification of Insulin-Resistant Subjects

Žofia Rádiková, J Koška, Miroslava Hučková et al. · Experimental and Clinical Endocrinology & Diabetes · 2006 · 153 citations